Table 3.
Uni and multivariate analyses of clinical factors affecting surgical complications.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | |
Male | 0.84 | 0.46‒1.51 | 0.568 | |||
Age > 65 | 1.53 | 0.85‒2.58 | 0.156 | |||
BMI > 25 | 1.31 | 0.72‒2.36 | 0.378 | |||
Regimen of fluid administration was SVV-guided | 0.50 | 0.27‒0.92 | 0.025 | 0.48 | 0.25‒0.91 | 0.025 |
Amount of fluids > 8 mL KgH | 0.74 | 0.41‒1.33 | 0.314 | |||
Type of fluids (both cristaloids and colloids) | 0.80 | 0.59‒1.09 | 0.168 | |||
Intraoperative use of vasopressors | 3.26 | 3.26‒20.01 | 0.201 | |||
Estimated blood loss was > 400 mL | 0.92 | 0.51‒1.66 | 0.771 | |||
Perioperative use of epidural | 0.38 | 0.15‒0.96 | 0.042 | 0.33 | 0.13‒0.87 | 0.025 |
Soft pancreatic gland texture | 2.29 | 1.26‒4.17 | 0.007 | 2.22 | 1.12‒4.40 | 0.022 |
Pancreatic Duct Size | ||||||
< 3 mm (vs. > 6 mm) | 0.39 | 0.16‒0.96 | 0.041 | 0.64 | 0.23‒1.75 | 0.382 |
3‒6 mm (vs. > 6 mm) | 0.68 | 0.34‒1.38 | 0.283 | 1.08 | 0.49‒2.41 | 0.842 |
> 6 mm | 1.00 | |||||
Diagnosis | ‒ | |||||
Cancer (vs. Benign) | 0.94 | 0.41‒2.12 | 0.873 | |||
NET (vs. Benign) | 1.14 | 0.29‒4.52 | 0.856 | |||
Benign | 1.00 | |||||
Duration of sugery > 400 min | 0.74 | 0.41‒1.33 | 0.316 |